Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts

Class:IdLiteratureReference:9750590
_displayName6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts
_timestamp2021-08-16 10:06:29
author[Person:9750620] Bökkerink, J P
[Person:9750552] Stet, E H
[Person:9750599] De Abreu, R A
[Person:9750550] Damen, F J
[Person:9750559] Hulscher, T W
[Person:9750551] Bakker, M A
[Person:9750604] van Baal, J A
created[InstanceEdit:9750573] Jassal, Bijay, 2021-08-16
journalBiochem Pharmacol
pages1455-63
pubMedIdentifier7682415
title6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts
volume45
year1993
(literatureReference)[Summation:9750561] Thiopurine methyltransferase (TPMT) can methylate thiopurine...
[Change default viewing format]
No pathways have been reviewed or authored by 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts (9750590)